Please login to the form below

Not currently logged in

FDA knocks back Amgen's chronic kidney disease treatment

Amgen flag

Parsabiv was hoped to equal or exceed solid earner Sensipar

AbbVie's venetoclax set for early access in UK

Drug for CLL patients included in EAMS by MHRA

Sanofi loses lead on diabetes combo IGlarLixi after FDA delay

Sanofi receptionFDA verdict on Novo Nordisk’s rival combo Xultophy due next month

AZ-Lilly start second pivotal trial of fast-tracked Alzheimer's drug

AstraZeneca AZAMARANTH could be first treatment to target underlying mechanism

Pfizer rides out Sanofi and confirms $14bn Medivation takeover

Success of cancer specialist’s drug Xtandi followed by work on other cancer drugs

Immunotherapy and future directions in oncology

How the field of cancer drugs is expanding as technology improves

Defining value: has anyone asked the patient?

The real-world challenges patients face give them unique views on ‘value’

FDA approves Lilly-backed Bluetooth insulin device

Clears Companion Medical’s Bluetooth-enabled pen and smartphone app

Lilly promotes Joshua Smiley to new finance role

He will replace Thomas Grein, who is retiring in next month


Why your gran’s not too old to be a millennial

And what does age really have to do with being a millennial?

AstraZeneca's Alastair MacDonald joins ClinTec

Takes up role at the Scottish CRO as global head of clinical operations

ClinTec Alastair MacDonald

AZ adds CV resources to diabetes programme

Expansion of Fit2Me also includes new Apple and Android mobile apps

AstraZeneca AZ diabetes cardiovascular Fit2Me

A rising tide

HBA Europe’s Claudia Graeve and Kathrin Schoenborn-Sobolewski on furthering women’s advancement in healthcare

Featured jobs

Subscribe to our email news alerts


Add my company

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

A stumble, but not a fall – what’s next for Opdivo?
Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results....
Blog: A new 'At your service' model for pharma
Turning the traditional sales model on its head to deliver commercial outcomes without selling at all...
Meet Anthill at conferences in London
October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit...